Soleno Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Soleno Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SLNO
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder.
CEOAnish Bhatnagar
CEOAnish Bhatnagar
Employees92
Employees92
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded1999
Founded1999
Employees92
Employees92
SLNO Key Statistics
Market cap2.49B
Market cap2.49B
Price-Earnings ratio-25.14
Price-Earnings ratio-25.14
Dividend yield—
Dividend yield—
Average volume1.09M
Average volume1.09M
High today$46.80
High today$46.80
Low today$45.07
Low today$45.07
Open price$46.14
Open price$46.14
Volume1.75M
Volume1.75M
52 Week high$90.32
52 Week high$90.32
52 Week low$41.50
52 Week low$41.50
Stock Snapshot
The current Soleno Therapeutics(SLNO) stock price is $46.30, with a market capitalization of 2.49B. The stock trades at a price-to-earnings (P/E) ratio of -25.14.
During the trading session on 2026-01-02, Soleno Therapeutics(SLNO) shares reached a daily high of $46.80 and a low of $45.07. At a current price of $46.30, the stock is +2.7% higher than the low and still -1.1% under the high.
Trading volume for Soleno Therapeutics(SLNO) stock has reached 1.75M, versus its average volume of 1.09M.
Over the past 52 weeks, Soleno Therapeutics(SLNO) stock has traded between a high of $90.32 and a low of $41.50.
Over the past 52 weeks, Soleno Therapeutics(SLNO) stock has traded between a high of $90.32 and a low of $41.50.
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SLNO. This list is generated using Robinhood data, and it’s not a recommendation.